Latest insights

The ECB: From Crisis Fighter to Liquidity Maestro?

Research Paper, Fixed Income, Pierre Boyer
The European Central Bank (ECB) has undergone a significant transformation, evolving from a passive observer to a proactive guardian of financial stability in the eurozone. As the ECB normalises its monetary policy after a period of unconventional measures, a key challenge has emerged: managing excess liquidity. This paper explores the ECB's evolving role in addressing this challenge.
  • Once upon a time, mankind invented PFAS (per- and polyfluoroalkyl substances).
    Bastien Dublanc, Astrid Pierard, Jessica Carlier, ESG, SRI, Equities, Research Paper, Water

    PFAS: Genius gone wrong

    PFAS have been widely used for decades due to their unique properties in various domestic and industrial applications. They are resistant to water and virtually indestructible. They are also seen as the poison of the century. Where do we stand in terms of regulation? What are the PFAS-related risks? Where are the opportunities?
6 results found
  • Oncology
Show me
  • Topic
  • Theme
  • Publication
  • Author
Show me
  • Topic
  • Theme
  • Publication
from
  • Author
6 results found
  • Oncology
ESG, SRI, Oncology

Advances in Healthcare and Oncology: A Pink October Perspective

Good news! The five-year survival rate for women diagnosed with breast cancer in the United States is now 90%[1]. Unfortunately, when looking at other statistics, the outlook worrying: one in eight women will develop an invasive form of breast cancer during their lifetime. In 2020, two million new cancer cases were diagnosed worldwide. Breast cancer is the most common cancer type among women and the second deadliest, following lung cancer. To better understand the urgency of treatments: in 2020, 685,000 women lost their lives from breast cancer.
Malgorzata Kluba, Rudi Van den Eynde, Oncology, Equities

World Cancer Day 2023

And we would rather not have to go through this – which would mean we won the battle and cancer is curable.
Oncology, Q&A, Rudi Van den Eynde, Equities

Investing in oncology: forewarned is forearmed

Rudi Van Den Eynde, Co-Head of Thematic Global Equity, and Linden Thomson, CFA, Senior Portfolio Manager, explain to investors the approach they used to create and develop an investment strategy in the oncology sector.
Oncology

World Cancer Day: How PRISM is helping to Close the Gap

The Candriam Institute provides financial support to the PRecISion Medicine Institute. The PRISM technology aims to save an additional 200,000 lives each year by identifying the unique molecular characteristics of each patient's cancer.
Oncology, ESG, SRI

World Cancer Day: How PRISM is helping to Close the Gap

The Candriam Institute provides financial support to the PRecISion Medicine Institute. The PRISM technology aims to save an additional 200,000 lives each year by identifying the unique molecular characteristics of each patient's cancer. With this information, more targeted treatment can be applied at each step, improving survival rates.
Oncology

Fight against cancer: Let’s write another story together

While cancer is still striking hard and remains among the leading causes of death globally, pharmaceutical innovation is continuing at a high pace. The patients’ survival rate keeps increasing, as is our understanding of the disease and its multiple forms deepens, and as breakthrough therapies are tested and launched. 

Find it fast

Get information faster with a single click

Get insights straight to your inbox